What is the current Core Biopsy Needles market size?

The Core Biopsy Needles market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Core Biopsy Needles market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Core Biopsy Needles market?

Increasing cancer incidence and advancements in biopsy technologies are key drivers.

What challenges does the Core Biopsy Needles market face?

High costs and limited accessibility in developing regions are significant challenges.

Which regions lead the Core Biopsy Needles market?

North America and Europe are regional leaders due to high healthcare expenditures.

Who are the top companies in the Core Biopsy Needles market?

Top companies include BD, Boston Scientific, and Medtronic, among others.

What future opportunities exist in the Core Biopsy Needles market?

Emerging markets and innovative technologies offer significant future outlook opportunities.

How does technology impact the Core Biopsy Needles market?

Advances in imaging and robotic technologies improve biopsy accuracy and efficiency.

What is the regulatory landscape for the Core Biopsy Needles market?

Stringent regulations and standards ensure product safety and efficacy.

What is the future outlook for the Core Biopsy Needles market size?

The market is expected to reach USD 1.8 billion by 2033, driven by growing demand.

Core Biopsy Needles Value Chain Analysis & Forecast Outlook 2033

Core Biopsy Needles by Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other), by Types (14G-18G, <14G, >18G), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Core Biopsy Needles Market Overview

The Core Biopsy Needles market refers to the global industry involved in the development, manufacturing, and distribution of core biopsy needles used for obtaining tissue samples from various parts of the body. As a critical component of diagnostic procedures, the Core Biopsy Needles market size is anticipated to experience significant growth, driven by an increasing demand for minimally invasive diagnostic techniques. The growth outlook for the Core Biopsy Needles market is positive, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. The industry expansion is expected to be driven by advancements in technology, shifting regulatory landscapes, and changing consumer behavior, ultimately leading to increased adoption of core biopsy needles across various medical specialties, including oncology, neurology, and cardiology.

Loading chart…

The current Core Biopsy Needles market size is approximately $1.3 billion. Key forces shaping the industry include technological advancements in needle design and materials, regulatory requirements for safety and efficacy, and changing consumer behavior driven by increased awareness of minimally invasive diagnostic options. The largest region for the Core Biopsy Needles market is North America, while the fastest-growing region is expected to be the Asia-Pacific. Overall, the Core Biopsy Needles market is poised for significant growth, driven by increasing demand for accurate and minimally invasive diagnostic procedures, ultimately leading to improved patient outcomes and enhanced market forecast.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD (Bard); Hologic; Mammotome; Argon Medical Devices; SOMATEX Medical Technologies; Invivo; M.D.L.; Sterylab; UROMED; Biopsybell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Core Biopsy Needles market is poised for significant growth, driven by factors such as the increasing prevalence of cancer and the rising demand for minimally invasive diagnostic procedures. This section provides an in-depth analysis of the market dynamics that are expected to shape the Core Biopsy Needles market size and growth forecast.

Growth Drivers2 items

Advancements in needle technology, such as the development of thinner and more precise needles, are expected to drive the adoption of core biopsy needles in various medical specialties, contributing to the growth of the Core Biopsy Needles market.

The increasing focus on personalized medicine and targeted therapies is also driving the demand for core biopsy needles, as they enable the collection of high-quality tissue samples for molecular analysis and diagnosis.

Restraints2 items

The high cost of core biopsy needles, particularly those with advanced features, is a significant restraint on the market, as it limits their adoption in resource-constrained healthcare settings.

The availability of alternative diagnostic techniques, such as fine-needle aspiration biopsy, may also hinder the growth of the Core Biopsy Needles market, as some healthcare providers may prefer these alternatives due to their lower cost and simplicity.

Opportunities2 items

The growing demand for core biopsy needles in emerging markets presents a significant opportunity for manufacturers to expand their customer base and increase their market share.

The development of new applications for core biopsy needles, such as in the diagnosis of infectious diseases, is also expected to drive market growth and increase the Core Biopsy Needles market size.

Challenges2 items

The Core Biopsy Needles market is highly competitive, with several established players competing for market share, which can make it challenging for new entrants to gain traction.

The need for stringent regulatory compliance and the potential for product recalls due to quality issues are also significant challenges that manufacturers must address to ensure the long-term sustainability of their businesses and maintain a positive growth forecast.

Market Segmentation

Loading chart…

The Core Biopsy Needles market can be segmented based on Application, which includes breast biopsy, lung biopsy, liver biopsy, and other biopsies. This segmentation contributes to the overall Core Biopsy Needles market size by highlighting the specific areas where core biopsy needles are most commonly used. Understanding the application-based segmentation is crucial for Core Biopsy Needles segmentation as it helps in identifying the target audience and developing strategies to cater to their needs.

Another way to segment the Core Biopsy Needles market is by Types, which includes subtypes such as automatic core biopsy needles and manual core biopsy needles. This segmentation is essential in determining the market size as it provides insights into the preferences of healthcare professionals and patients. The types of core biopsy needles used can significantly impact the overall market size, and analyzing this segmentation can help in understanding the market taxonomy of the Core Biopsy Needles industry.

Core Biopsy Needles Segmentation Breakdown10 items

Application

Lung Cancer

Liver Cancer

Breast Cancer

Prostate Cancer

Other

Types

14G-18G

<14G

>18G

Regional Insights

Loading chart…

The Core Biopsy Needles market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing investment in research and development, and a growing aging population. Asia Pacific is driven by rapid urbanization, a large and growing population, and increasing access to healthcare. Latin America and Middle East & Africa are driven by emerging markets, growing demand for healthcare services, and increasing foreign investment.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by government initiatives to improve healthcare access and quality. In contrast, Latin America and Middle East & Africa are expected to experience moderate growth, driven by economic factors and regulatory challenges. Understanding these regional dynamics is crucial for stakeholders to navigate the Core Biopsy Needles market and capitalize on emerging opportunities.

Competitive Landscape

The Core Biopsy Needles market is moderately consolidated, with a mix of global players and local companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The Core Biopsy Needles competitive landscape is driven by the ability of companies to balance these levers and adapt to changing market conditions. Global players tend to focus on product innovation and regulatory approvals, while local companies often prioritize distribution and pricing strategies.

Companies in the market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are responding by focusing on specific strategic initiatives, such as:

BD: regional expansion

Hologic: innovation pipeline

Mammotome: premium pricing

Argon Medical Devices: OEM tie-ups

SOMATEX Medical Technologies: local manufacturing

Invivo: vertical integration

Key Core Biopsy Needles Companies10 items

BD (Bard)

Hologic

Mammotome

Argon Medical Devices

SOMATEX Medical Technologies

Invivo

M.D.L.

Sterylab

UROMED

Biopsybell

Market Ecosystem

The Core Biopsy Needles ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of core biopsy needles, with each segment influencing the overall efficiency and effectiveness of the ecosystem. Understanding the Core Biopsy Needles ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — provide needle materials

OEMs / manufacturers — produce core biopsy needles

Technology providers — develop needle technologies

Distributors / channel partners — supply needles to healthcare facilities

Service providers / after-sales — offer maintenance and support

End users / buyers — healthcare professionals and facilities

Regulators/standards bodies — establish safety and quality standards

The flow of value within the Core Biopsy Needles ecosystem is influenced by various control points, including regulatory approvals and standards set by regulators/standards bodies. Dependency risks, such as input constraints and approvals, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The ecosystem's dynamics can also vary by region, with different regions having distinct regulatory requirements, market conditions, and customer needs.

Recent Industry Insights

The Core Biopsy Needles industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships and collaborations have been formed to enhance product portfolios and expand market reach. Recent mergers and acquisitions have also led to increased consolidation in the industry, resulting in improved operational efficiencies. Furthermore, several companies have launched innovative products and technologies, such as advanced needle designs and imaging systems, to improve biopsy procedures and patient outcomes.

Additionally, regulatory changes have driven the adoption of core biopsy needles in various medical specialties, and shifts in consumer and enterprise trends have led to increased demand for minimally invasive diagnostic procedures. Funding rounds and expansions have also been secured by key players to support research and development initiatives, underscoring the growth potential of the Core Biopsy Needles industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Core Biopsy Needles market outlook. The market attractiveness is driven by the increasing prevalence of cancer and the growing demand for minimally invasive diagnostic procedures. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios.

The long-term outlook for the Core Biopsy Needles market is positive, with a growing demand for advanced diagnostic technologies. The innovation landscape is characterized by the development of next-generation biopsy needles with improved accuracy and safety features. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and fluctuations in raw material prices.

Key Takeaways3 items

The Core Biopsy Needles market outlook is driven by increasing cancer prevalence and demand for minimally invasive diagnostics

Moderate competitive intensity with a focus on innovation and portfolio expansion

Long-term growth potential with a growing demand for advanced diagnostic technologies

11 items

1. Executive Summary

2. Core Biopsy Needles Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Core Biopsy Needles Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Core Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Lung Cancer

6.1.2. Liver Cancer

6.1.3. Breast Cancer

6.1.4. Prostate Cancer

6.1.5. Other

6.2. Global Core Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 14G-18G

6.2.2. <14G

6.2.3. >18G

6.3. Global Core Biopsy Needles Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Core Biopsy Needles Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Core Biopsy Needles Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Core Biopsy Needles Market Competition by Key Manufacturers

8.1. Global Core Biopsy Needles Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Core Biopsy Needles: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD (Bard)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Hologic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mammotome

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Argon Medical Devices

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. SOMATEX Medical Technologies

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Invivo

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. M.D.L.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sterylab

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. UROMED

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Biopsybell

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Core Biopsy Needles Market

Figure 4: Global Core Biopsy Needles Market: Drivers

Figure 5: Global Core Biopsy Needles Market: Challenges

Figure 6: Global Core Biopsy Needles Market: Trends

Figure 7: Global Core Biopsy Needles Market: Opportunity

Figure 8: Global Core Biopsy Needles Market: Restraint

Figure 9: Global Core Biopsy Needles Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Core Biopsy Needles Market Value (USD Million) By Region

Figure 15: Global Core Biopsy Needles Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Core Biopsy Needles Market Value (USD Million) By Region

Figure 23: Global Core Biopsy Needles Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Core Biopsy Needles Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Core Biopsy Needles Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Core Biopsy Needles Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Core Biopsy Needles Market Value (USD Million) By Region

Table 10: Global Core Biopsy Needles Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Core Biopsy Needles Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Core Biopsy Needles Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Core Biopsy Needles Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD (Bard) Basic Information And Sales Area

Table 31: BD (Bard). Products Portfolio

Table 32: Hologic Basic Information And Sales Area

Table 33: Hologic. Products Portfolio

Table 34: Mammotome Basic Information And Sales Area

Table 35: Mammotome. Products Portfolio

Table 36: Argon Medical Devices Basic Information And Sales Area

Table 37: Argon Medical Devices. Products Portfolio

Table 38: SOMATEX Medical Technologies Basic Information And Sales Area

Table 39: SOMATEX Medical Technologies. Products Portfolio

Table 40: Invivo Basic Information And Sales Area

Table 41: Invivo. Products Portfolio

Table 42: M.D.L. Basic Information And Sales Area

Table 43: M.D.L.. Products Portfolio

Table 44: Sterylab Basic Information And Sales Area

Table 45: Sterylab. Products Portfolio

Table 46: UROMED Basic Information And Sales Area

Table 47: UROMED. Products Portfolio

Table 48: Biopsybell Basic Information And Sales Area

Table 49: Biopsybell. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Core Biopsy Needles Market Value (USD Million) By Region

Table 55: Global Core Biopsy Needles Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Core Biopsy Needles Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD (Bard); Hologic; Mammotome; Argon Medical Devices; SOMATEX Medical Technologies; Invivo; M.D.L.; Sterylab; UROMED; Biopsybell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The high cost of core biopsy needles, particularly those with advanced features, is a significant restraint on the market, as it limits their adoption in resource-constrained healthcare settings.

Opportunities2 items

The growing demand for core biopsy needles in emerging markets presents a significant opportunity for manufacturers to expand their customer base and increase their market share.

Challenges2 items

The Core Biopsy Needles market is highly competitive, with several established players competing for market share, which can make it challenging for new entrants to gain traction.

Market Segmentation

Loading chart…

Core Biopsy Needles Segmentation Breakdown10 items

Application

Lung Cancer

Liver Cancer

Breast Cancer

Prostate Cancer

Other

Types

14G-18G

<14G

>18G

Regional Insights

Loading chart…

Competitive Landscape

BD: regional expansion

Hologic: innovation pipeline

Mammotome: premium pricing

Argon Medical Devices: OEM tie-ups

SOMATEX Medical Technologies: local manufacturing

Invivo: vertical integration

Key Core Biopsy Needles Companies10 items

BD (Bard)

Hologic

Mammotome

Argon Medical Devices

SOMATEX Medical Technologies

Invivo

M.D.L.

Sterylab

UROMED

Biopsybell

Market Ecosystem

Raw material suppliers — provide needle materials

OEMs / manufacturers — produce core biopsy needles

Technology providers — develop needle technologies

Distributors / channel partners — supply needles to healthcare facilities

Service providers / after-sales — offer maintenance and support

End users / buyers — healthcare professionals and facilities

Regulators/standards bodies — establish safety and quality standards

Recent Industry Insights

Analyst Overview

Key Takeaways3 items

The Core Biopsy Needles market outlook is driven by increasing cancer prevalence and demand for minimally invasive diagnostics

Moderate competitive intensity with a focus on innovation and portfolio expansion

Long-term growth potential with a growing demand for advanced diagnostic technologies

Table of Contents